Printer Friendly
The Free Library
19,111,409 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Novartis Ophthalmics Selects CommonHealth Units for Visudyne Marketing; Noesis Healthcare Interactions to Develop Professional Advertising for the Drug.


Business Editors/Health/Medical Writers

PARSIPPANY, N.J.--(BUSINESS WIRE)--June 10, 2004

The Xchange Group to Handle Customer Relationship-Marketing

Programs

CommonHealth today announced that Noesis Healthcare Interactions, its Morristown-based professional advertising and promotion agency, and The Xchange Group, its relationship-marketing unit, have been awarded professional and customer relationship-marketing responsibilities, respectively, for Novartis Ophthalmics' Visudyne, an FDA-approved therapy for patients with wet age-related macular degeneration Age-related macular degeneration (ARMD)
Degeneration of the macula (the central part of the retina where the rods and cones are most dense) that leads to loss of central vision in people over 60.
 (AMD (Advanced Micro Devices, Inc., Sunnyvale, CA, www.amd.com) A major manufacturer of semiconductor devices including x86-compatible CPUs, embedded processors, flash memories, programmable logic devices and networking chips. ).

CommonHealth (www.commonhealth.com) is the world's leading healthcare-communications resource and a WPP Group (LSE LSE - Language Sensitive Editor : WPPL WPPL White Plains Public Library (New York)
WPPL Wireless Point to Point Link
WPPL Welding Performance Proficiency Log
.L; NASDAQ/ADR: WPPGY; www.wpp WPP Wire & Plastic Product PLC
WPP World Press Photo
WPP Web Presence Provider
WPP Wolf Pack Productions (anime fan subbing group)
WPP Witness Protection Program
WPP Wireless Packet Platform
WPP Work Package Planning
.com) company.

An infusion drug treatment activated by a non-heat-producing laser, Visudyne therapy alters the course of AMD, slowing abnormal vessel growth and progression of vision loss.

"This new assignment is the continuation of a long-standing, highly successful relationship between Noesis and Novartis," noted Bruce Epstein, president of Noesis Healthcare Interactions. "We look forward to working in conjunction with the Novartis team to increase professional awareness of the benefits of Visudyne for patients affected by AMD."

"Each year, 200,000 people are diagnosed with AMD -- the leading cause of severe vision loss among the elderly," added Nancy Barlow, president of The Xchange Group. "We're thrilled to have been selected by Novartis to develop and execute relationship-building initiatives for this effective therapy."

CommonHealth comprises Noesis Healthcare Interactions, The Xchange Group, Thomas Ferguson Associates, Adient, The Quantum Group, Carbon Healthcare Communications, Solara, Health Learning Systems, ProCom International, The Conectics Group, MBS/Vox, Enterprise IG Health, EinsonHealth, MD/Salud, Shire Health New York, CommonHealth Europe, CommonHealth Australia and CommonHealth Kyowa.

CommonHealth also has partnerships with the following companies: Ogilvy Healthcare Network, Media Marketing Solutions, Medical Broadcasting Company (MBC (Multimedia Benchmark Committee) A graphics benchmark that provides MPEG-2 and other tests. See GPC. ) and PDI PDI Protein Disulfide Isomerase
PDI Personal Docente e Investigador (Spanish: Personal Educational and Investigating)
PDI Pre Delivery Inspection
PDI Professional Development Institute
.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 10, 2004
Words:275
Previous Article:REMINDER/South Florida Interactive Marketing Association Holds June Program ''Websites That Drive Customer Acquisition''.
Next Article:Phil Gallagher Named New President of Avnet Electronics Marketing Americas.



Related Articles
CommonHealth Wins Novartis Non-Steroidal Eczema-Therapy Assignment; First in a New Class of Drugs Targeting Inflammatory Skin Disease.
Epstein Named General Manager of Noesis.
Bruce Epstein Named President of Noesis Healthcare Interactions.
CommonHealth Units Recognized for Creative Excellence.
Creativity to Drive Growth at Noesis - John Nosta Appointed Chief Creative Officer.
CommonHealth Units Honored for Outstanding Creative Work.
Noesis Healthcare Interactions Welcomes New Hire to Account Management Team.
CommonHealth's Quantum Group Awarded Gold by the Rx Club.
Novartis Selects CommonHealth's Noesis for Transplant Business.
CommonHealth Unveils New Operating Philosophy and Corporate Identity.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles